Jasper Therapeutics, Inc. (JSPR) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts JSPR Hot Sheet
Join SI Premium – FREE
Jasper Therapeutics, Inc. (NASDAQ: JSPR) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Jasper Therapeutics, Inc. (JSPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
